What is Andres Redondo's NPI number?

Andres Redondo's National Provider Identifier (NPI) is 1558369165, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Andres Redondo's specialty?

Andres Redondo is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Andres Redondo located?

Andres Redondo's practice location on file with NPPES is 3181 Sw 22 Street, Miami, FL 33145-3216.

What is Andres Redondo's phone number?

The practice phone number listed in the NPPES registry for Andres Redondo is (305) 567-1999.

Does Andres Redondo accept Medicare?

Andres Redondo is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Andres Redondo's NPI active?

Yes — Andres Redondo's NPI (1558369165) is active in the NPPES registry as of the last update on 2010-06-17.

IndividualActiveAccepts Medicare

Andres Redondo, MD

NPI 1558369165 · Pulmonary Disease Physician · Miami, FL

Andres Redondo, MD is a Pulmonary Disease Physician provider in Miami, FL (NPI 1558369165).

Provider details

NPI number: 1558369165
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: ME0045903 (FL)

Practice location

3181 Sw 22 Street

2nd Floor

Miami, FL 33145-3216

Phone: (305) 567-1999

Fax: (305) 567-9309

Street-level locationGet directions

More FL providers

Mailing address

3181 Sw 22 Street

Miami, FL 33145-3216

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense ME0045903 (FL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(78/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
21 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
963 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	342	$143
Evaluation of Use of Breathing Device94664	150	$20
Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060	95	$43
Test to Examine How Well the Lungs Exchange Gases94729	93	$61
Test to Determine Lung Volumes Using Gas Dilution Or Washout94727	92	$49
X-Ray of Chest, 2 Views71046	88	$37

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 52 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	3,000	737
Fluticasone Propionate	1,713	476
Montelukast Sodium	1,533	398
Fluticasone/Vilanterolbrand: Breo Ellipta	1,002	217
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	964	191
Tiotropium Bromidebrand: Spiriva Respimat	907	207

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$477 across 23 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2005-07-08
Last updated: 2010-06-17

Frequently asked questions

What is Andres Redondo's NPI number?: Andres Redondo's National Provider Identifier (NPI) is 1558369165, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Andres Redondo's specialty?: Andres Redondo is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Andres Redondo located?: Andres Redondo's practice location on file with NPPES is 3181 Sw 22 Street, Miami, FL 33145-3216.
What is Andres Redondo's phone number?: The practice phone number listed in the NPPES registry for Andres Redondo is (305) 567-1999.
Does Andres Redondo accept Medicare?: Andres Redondo is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Andres Redondo's NPI active?: Yes — Andres Redondo's NPI (1558369165) is active in the NPPES registry as of the last update on 2010-06-17.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	342	$143
Evaluation of Use of Breathing Device94664	150	$20
Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060	95	$43
Test to Examine How Well the Lungs Exchange Gases94729	93	$61
Test to Determine Lung Volumes Using Gas Dilution Or Washout94727	92	$49
X-Ray of Chest, 2 Views71046	88	$37

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 52 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	3,000	737
Fluticasone Propionate	1,713	476
Montelukast Sodium	1,533	398
Fluticasone/Vilanterolbrand: Breo Ellipta	1,002	217
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	964	191
Tiotropium Bromidebrand: Spiriva Respimat	907	207

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$477 across 23 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments